Get Real Time Here
| Open1.670 | Close1.660 |
| Vol / Avg.330.223K / 899.851K | Mkt Cap120.256M |
| Day Range1.650 - 1.700 | 52 Wk Range1.000 - 3.550 |
Protalix BioTherapeutics Stock (AMEX:PLX), Quotes and News Summary
Protalix BioTherapeutics Stock (AMEX: PLX) stock price, news, charts, stock research, profile.
| Open1.670 | Close1.660 |
| Vol / Avg.330.223K / 899.851K | Mkt Cap120.256M |
| Day Range1.650 - 1.700 | 52 Wk Range1.000 - 3.550 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.040 | 0.210 | 0.2500 | ||||
| REV | 10.220M | 35.075M | 24.855M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2021-05-03 | HC Wainwright & Co. | Raghuram Selvaraju | Maintains | Buy | Lowers | 11.00 | 7.00 |
| 2020-06-08 | HC Wainwright & Co. | Raghuram Selvaraju | Maintains | Buy | Raises | 3.00 | 11.00 |
| 2017-04-17 | Rodman & Renshaw | Raghuram Selvaraju | Reiterates | Buy | Raises | 4.00 | 5.00 |
| 2016-09-06 | Jefferies | - | Maintains | Buy | Lowers | 1.75 | 0.80 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| PLX | Protalix BioTherapeutics | -1.75% | 120.3M |
| GRPH | Graphite Bio | -1.25% | 137.4M |
| ANIX | Anixa Biosciences | 1.19% | 105.6M |
| GALT | Galectin Therapeutics | 0.56% | 106.7M |
| PEPG | PepGen | 2.04% | 131M |
How do I buy Protalix BioTherapeutics (PLX) stock?
You can purchase shares of Protalix BioTherapeutics (AMEX: PLX) through any online brokerage.
Who are Protalix BioTherapeutics's (PLX) competitors?
Other companies in Protalix BioTherapeutics’s space includes: Graphite Bio (NASDAQ:GRPH), Anixa Biosciences (NASDAQ:ANIX), Galectin Therapeutics (NASDAQ:GALT), PepGen (NASDAQ:PEPG) and Gritstone Bio (NASDAQ:GRTS).
What is the target price for Protalix BioTherapeutics (PLX) stock?
The latest price target for Protalix BioTherapeutics (AMEX: PLX) was reported by HC Wainwright & Co. on Monday, May 3, 2021. The analyst firm set a price target for 7.00 expecting PLX to rise to within 12 months (a possible 316.67% upside). 0 analyst firms have reported ratings in the last year.
Current Stock Price for Protalix BioTherapeutics (PLX)?
The stock price for Protalix BioTherapeutics (AMEX: PLX) is $1.68 last updated September 21, 2023 at 7:59 PM UTC.
Does Protalix BioTherapeutics (PLX) pay a dividend?
There is no dividend information for Protalix BioTherapeutics.
When is Protalix BioTherapeutics (AMEX:PLX) reporting earnings?
Protalix BioTherapeutics’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Protalix BioTherapeutics (PLX) going to split?
There is no upcoming split for Protalix BioTherapeutics.
What sector and industry does Protalix BioTherapeutics (PLX) operate in?
Protalix BioTherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.
Protalix BioTherapeutics Stock (AMEX:PLX), Quotes and News Summary
Protalix BioTherapeutics Stock (AMEX: PLX) stock price, news, charts, stock research, profile.
| Open1.670 | Close1.660 |
| Vol / Avg.330.223K / 899.851K | Mkt Cap120.256M |
| Day Range1.650 - 1.700 | 52 Wk Range1.000 - 3.550 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.040 | 0.210 | 0.2500 | ||||
| REV | 10.220M | 35.075M | 24.855M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2021-05-03 | HC Wainwright & Co. | Raghuram Selvaraju | Maintains | Buy | Lowers | 11.00 | 7.00 |
| 2020-06-08 | HC Wainwright & Co. | Raghuram Selvaraju | Maintains | Buy | Raises | 3.00 | 11.00 |
| 2017-04-17 | Rodman & Renshaw | Raghuram Selvaraju | Reiterates | Buy | Raises | 4.00 | 5.00 |
| 2016-09-06 | Jefferies | - | Maintains | Buy | Lowers | 1.75 | 0.80 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| PLX | Protalix BioTherapeutics | -1.75% | 120.3M |
| GRPH | Graphite Bio | -1.25% | 137.4M |
| ANIX | Anixa Biosciences | 1.19% | 105.6M |
| GALT | Galectin Therapeutics | 0.56% | 106.7M |
| PEPG | PepGen | 2.04% | 131M |
How do I buy Protalix BioTherapeutics (PLX) stock?
You can purchase shares of Protalix BioTherapeutics (AMEX: PLX) through any online brokerage.
Who are Protalix BioTherapeutics's (PLX) competitors?
Other companies in Protalix BioTherapeutics’s space includes: Graphite Bio (NASDAQ:GRPH), Anixa Biosciences (NASDAQ:ANIX), Galectin Therapeutics (NASDAQ:GALT), PepGen (NASDAQ:PEPG) and Gritstone Bio (NASDAQ:GRTS).
What is the target price for Protalix BioTherapeutics (PLX) stock?
The latest price target for Protalix BioTherapeutics (AMEX: PLX) was reported by HC Wainwright & Co. on Monday, May 3, 2021. The analyst firm set a price target for 7.00 expecting PLX to rise to within 12 months (a possible 316.67% upside). 0 analyst firms have reported ratings in the last year.
Current Stock Price for Protalix BioTherapeutics (PLX)?
The stock price for Protalix BioTherapeutics (AMEX: PLX) is $1.68 last updated September 21, 2023 at 7:59 PM UTC.
Does Protalix BioTherapeutics (PLX) pay a dividend?
There is no dividend information for Protalix BioTherapeutics.
When is Protalix BioTherapeutics (AMEX:PLX) reporting earnings?
Protalix BioTherapeutics’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Protalix BioTherapeutics (PLX) going to split?
There is no upcoming split for Protalix BioTherapeutics.
What sector and industry does Protalix BioTherapeutics (PLX) operate in?
Protalix BioTherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.
Protalix BioTherapeutics Stock (AMEX:PLX), Quotes and News Summary
Protalix BioTherapeutics Stock (AMEX: PLX) stock price, news, charts, stock research, profile.
| Open1.670 | Close1.660 |
| Vol / Avg.330.223K / 899.851K | Mkt Cap120.256M |
| Day Range1.650 - 1.700 | 52 Wk Range1.000 - 3.550 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.040 | 0.210 | 0.2500 | ||||
| REV | 10.220M | 35.075M | 24.855M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2021-05-03 | HC Wainwright & Co. | Raghuram Selvaraju | Maintains | Buy | Lowers | 11.00 | 7.00 |
| 2020-06-08 | HC Wainwright & Co. | Raghuram Selvaraju | Maintains | Buy | Raises | 3.00 | 11.00 |
| 2017-04-17 | Rodman & Renshaw | Raghuram Selvaraju | Reiterates | Buy | Raises | 4.00 | 5.00 |
| 2016-09-06 | Jefferies | - | Maintains | Buy | Lowers | 1.75 | 0.80 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| PLX | Protalix BioTherapeutics | -1.75% | 120.3M |
| GRPH | Graphite Bio | -1.25% | 137.4M |
| ANIX | Anixa Biosciences | 1.19% | 105.6M |
| GALT | Galectin Therapeutics | 0.56% | 106.7M |
| PEPG | PepGen | 2.04% | 131M |
How do I buy Protalix BioTherapeutics (PLX) stock?
You can purchase shares of Protalix BioTherapeutics (AMEX: PLX) through any online brokerage.
Who are Protalix BioTherapeutics's (PLX) competitors?
Other companies in Protalix BioTherapeutics’s space includes: Graphite Bio (NASDAQ:GRPH), Anixa Biosciences (NASDAQ:ANIX), Galectin Therapeutics (NASDAQ:GALT), PepGen (NASDAQ:PEPG) and Gritstone Bio (NASDAQ:GRTS).
What is the target price for Protalix BioTherapeutics (PLX) stock?
The latest price target for Protalix BioTherapeutics (AMEX: PLX) was reported by HC Wainwright & Co. on Monday, May 3, 2021. The analyst firm set a price target for 7.00 expecting PLX to rise to within 12 months (a possible 316.67% upside). 0 analyst firms have reported ratings in the last year.
Current Stock Price for Protalix BioTherapeutics (PLX)?
The stock price for Protalix BioTherapeutics (AMEX: PLX) is $1.68 last updated September 21, 2023 at 7:59 PM UTC.
Does Protalix BioTherapeutics (PLX) pay a dividend?
There is no dividend information for Protalix BioTherapeutics.
When is Protalix BioTherapeutics (AMEX:PLX) reporting earnings?
Protalix BioTherapeutics’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Protalix BioTherapeutics (PLX) going to split?
There is no upcoming split for Protalix BioTherapeutics.
What sector and industry does Protalix BioTherapeutics (PLX) operate in?
Protalix BioTherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.
Protalix BioTherapeutics Stock (AMEX:PLX), Quotes and News Summary
Protalix BioTherapeutics Stock (AMEX: PLX) stock price, news, charts, stock research, profile.
| Open1.670 | Close1.660 |
| Vol / Avg.330.223K / 899.851K | Mkt Cap120.256M |
| Day Range1.650 - 1.700 | 52 Wk Range1.000 - 3.550 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.040 | 0.210 | 0.2500 | ||||
| REV | 10.220M | 35.075M | 24.855M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2021-05-03 | HC Wainwright & Co. | Raghuram Selvaraju | Maintains | Buy | Lowers | 11.00 | 7.00 |
| 2020-06-08 | HC Wainwright & Co. | Raghuram Selvaraju | Maintains | Buy | Raises | 3.00 | 11.00 |
| 2017-04-17 | Rodman & Renshaw | Raghuram Selvaraju | Reiterates | Buy | Raises | 4.00 | 5.00 |
| 2016-09-06 | Jefferies | - | Maintains | Buy | Lowers | 1.75 | 0.80 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| PLX | Protalix BioTherapeutics | -1.75% | 120.3M |
| GRPH | Graphite Bio | -1.25% | 137.4M |
| ANIX | Anixa Biosciences | 1.19% | 105.6M |
| GALT | Galectin Therapeutics | 0.56% | 106.7M |
| PEPG | PepGen | 2.04% | 131M |
How do I buy Protalix BioTherapeutics (PLX) stock?
You can purchase shares of Protalix BioTherapeutics (AMEX: PLX) through any online brokerage.
Who are Protalix BioTherapeutics's (PLX) competitors?
Other companies in Protalix BioTherapeutics’s space includes: Graphite Bio (NASDAQ:GRPH), Anixa Biosciences (NASDAQ:ANIX), Galectin Therapeutics (NASDAQ:GALT), PepGen (NASDAQ:PEPG) and Gritstone Bio (NASDAQ:GRTS).
What is the target price for Protalix BioTherapeutics (PLX) stock?
The latest price target for Protalix BioTherapeutics (AMEX: PLX) was reported by HC Wainwright & Co. on Monday, May 3, 2021. The analyst firm set a price target for 7.00 expecting PLX to rise to within 12 months (a possible 316.67% upside). 0 analyst firms have reported ratings in the last year.
Current Stock Price for Protalix BioTherapeutics (PLX)?
The stock price for Protalix BioTherapeutics (AMEX: PLX) is $1.68 last updated September 21, 2023 at 7:59 PM UTC.
Does Protalix BioTherapeutics (PLX) pay a dividend?
There is no dividend information for Protalix BioTherapeutics.
When is Protalix BioTherapeutics (AMEX:PLX) reporting earnings?
Protalix BioTherapeutics’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Protalix BioTherapeutics (PLX) going to split?
There is no upcoming split for Protalix BioTherapeutics.
What sector and industry does Protalix BioTherapeutics (PLX) operate in?
Protalix BioTherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.
Protalix BioTherapeutics Stock (AMEX:PLX), Quotes and News Summary
Protalix BioTherapeutics Stock (AMEX: PLX) stock price, news, charts, stock research, profile.
| Open1.670 | Close1.660 |
| Vol / Avg.330.223K / 899.851K | Mkt Cap120.256M |
| Day Range1.650 - 1.700 | 52 Wk Range1.000 - 3.550 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.040 | 0.210 | 0.2500 | ||||
| REV | 10.220M | 35.075M | 24.855M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2021-05-03 | HC Wainwright & Co. | Raghuram Selvaraju | Maintains | Buy | Lowers | 11.00 | 7.00 |
| 2020-06-08 | HC Wainwright & Co. | Raghuram Selvaraju | Maintains | Buy | Raises | 3.00 | 11.00 |
| 2017-04-17 | Rodman & Renshaw | Raghuram Selvaraju | Reiterates | Buy | Raises | 4.00 | 5.00 |
| 2016-09-06 | Jefferies | - | Maintains | Buy | Lowers | 1.75 | 0.80 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| PLX | Protalix BioTherapeutics | -1.75% | 120.3M |
| GRPH | Graphite Bio | -1.25% | 137.4M |
| ANIX | Anixa Biosciences | 1.19% | 105.6M |
| GALT | Galectin Therapeutics | 0.56% | 106.7M |
| PEPG | PepGen | 2.04% | 131M |
How do I buy Protalix BioTherapeutics (PLX) stock?
You can purchase shares of Protalix BioTherapeutics (AMEX: PLX) through any online brokerage.
Who are Protalix BioTherapeutics's (PLX) competitors?
Other companies in Protalix BioTherapeutics’s space includes: Graphite Bio (NASDAQ:GRPH), Anixa Biosciences (NASDAQ:ANIX), Galectin Therapeutics (NASDAQ:GALT), PepGen (NASDAQ:PEPG) and Gritstone Bio (NASDAQ:GRTS).
What is the target price for Protalix BioTherapeutics (PLX) stock?
The latest price target for Protalix BioTherapeutics (AMEX: PLX) was reported by HC Wainwright & Co. on Monday, May 3, 2021. The analyst firm set a price target for 7.00 expecting PLX to rise to within 12 months (a possible 316.67% upside). 0 analyst firms have reported ratings in the last year.
Current Stock Price for Protalix BioTherapeutics (PLX)?
The stock price for Protalix BioTherapeutics (AMEX: PLX) is $1.68 last updated September 21, 2023 at 7:59 PM UTC.
Does Protalix BioTherapeutics (PLX) pay a dividend?
There is no dividend information for Protalix BioTherapeutics.
When is Protalix BioTherapeutics (AMEX:PLX) reporting earnings?
Protalix BioTherapeutics’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Protalix BioTherapeutics (PLX) going to split?
There is no upcoming split for Protalix BioTherapeutics.
What sector and industry does Protalix BioTherapeutics (PLX) operate in?
Protalix BioTherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.
Protalix BioTherapeutics Stock (AMEX:PLX), Quotes and News Summary
Protalix BioTherapeutics Stock (AMEX: PLX) stock price, news, charts, stock research, profile.
| Open1.670 | Close1.660 |
| Vol / Avg.330.223K / 899.851K | Mkt Cap120.256M |
| Day Range1.650 - 1.700 | 52 Wk Range1.000 - 3.550 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.040 | 0.210 | 0.2500 | ||||
| REV | 10.220M | 35.075M | 24.855M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2021-05-03 | HC Wainwright & Co. | Raghuram Selvaraju | Maintains | Buy | Lowers | 11.00 | 7.00 |
| 2020-06-08 | HC Wainwright & Co. | Raghuram Selvaraju | Maintains | Buy | Raises | 3.00 | 11.00 |
| 2017-04-17 | Rodman & Renshaw | Raghuram Selvaraju | Reiterates | Buy | Raises | 4.00 | 5.00 |
| 2016-09-06 | Jefferies | - | Maintains | Buy | Lowers | 1.75 | 0.80 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| PLX | Protalix BioTherapeutics | -1.75% | 120.3M |
| GRPH | Graphite Bio | -1.25% | 137.4M |
| ANIX | Anixa Biosciences | 1.19% | 105.6M |
| GALT | Galectin Therapeutics | 0.56% | 106.7M |
| PEPG | PepGen | 2.04% | 131M |
How do I buy Protalix BioTherapeutics (PLX) stock?
You can purchase shares of Protalix BioTherapeutics (AMEX: PLX) through any online brokerage.
Who are Protalix BioTherapeutics's (PLX) competitors?
Other companies in Protalix BioTherapeutics’s space includes: Graphite Bio (NASDAQ:GRPH), Anixa Biosciences (NASDAQ:ANIX), Galectin Therapeutics (NASDAQ:GALT), PepGen (NASDAQ:PEPG) and Gritstone Bio (NASDAQ:GRTS).
What is the target price for Protalix BioTherapeutics (PLX) stock?
The latest price target for Protalix BioTherapeutics (AMEX: PLX) was reported by HC Wainwright & Co. on Monday, May 3, 2021. The analyst firm set a price target for 7.00 expecting PLX to rise to within 12 months (a possible 316.67% upside). 0 analyst firms have reported ratings in the last year.
Current Stock Price for Protalix BioTherapeutics (PLX)?
The stock price for Protalix BioTherapeutics (AMEX: PLX) is $1.68 last updated September 21, 2023 at 7:59 PM UTC.
Does Protalix BioTherapeutics (PLX) pay a dividend?
There is no dividend information for Protalix BioTherapeutics.
When is Protalix BioTherapeutics (AMEX:PLX) reporting earnings?
Protalix BioTherapeutics’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Protalix BioTherapeutics (PLX) going to split?
There is no upcoming split for Protalix BioTherapeutics.
What sector and industry does Protalix BioTherapeutics (PLX) operate in?
Protalix BioTherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.
Protalix BioTherapeutics Stock (AMEX:PLX), Quotes and News Summary
Protalix BioTherapeutics Stock (AMEX: PLX) stock price, news, charts, stock research, profile.
| Open1.670 | Close1.660 |
| Vol / Avg.330.223K / 899.851K | Mkt Cap120.256M |
| Day Range1.650 - 1.700 | 52 Wk Range1.000 - 3.550 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.040 | 0.210 | 0.2500 | ||||
| REV | 10.220M | 35.075M | 24.855M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2021-05-03 | HC Wainwright & Co. | Raghuram Selvaraju | Maintains | Buy | Lowers | 11.00 | 7.00 |
| 2020-06-08 | HC Wainwright & Co. | Raghuram Selvaraju | Maintains | Buy | Raises | 3.00 | 11.00 |
| 2017-04-17 | Rodman & Renshaw | Raghuram Selvaraju | Reiterates | Buy | Raises | 4.00 | 5.00 |
| 2016-09-06 | Jefferies | - | Maintains | Buy | Lowers | 1.75 | 0.80 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| PLX | Protalix BioTherapeutics | -1.75% | 120.3M |
| GRPH | Graphite Bio | -1.25% | 137.4M |
| ANIX | Anixa Biosciences | 1.19% | 105.6M |
| GALT | Galectin Therapeutics | 0.56% | 106.7M |
| PEPG | PepGen | 2.04% | 131M |
How do I buy Protalix BioTherapeutics (PLX) stock?
You can purchase shares of Protalix BioTherapeutics (AMEX: PLX) through any online brokerage.
Who are Protalix BioTherapeutics's (PLX) competitors?
Other companies in Protalix BioTherapeutics’s space includes: Graphite Bio (NASDAQ:GRPH), Anixa Biosciences (NASDAQ:ANIX), Galectin Therapeutics (NASDAQ:GALT), PepGen (NASDAQ:PEPG) and Gritstone Bio (NASDAQ:GRTS).
What is the target price for Protalix BioTherapeutics (PLX) stock?
The latest price target for Protalix BioTherapeutics (AMEX: PLX) was reported by HC Wainwright & Co. on Monday, May 3, 2021. The analyst firm set a price target for 7.00 expecting PLX to rise to within 12 months (a possible 316.67% upside). 0 analyst firms have reported ratings in the last year.
Current Stock Price for Protalix BioTherapeutics (PLX)?
The stock price for Protalix BioTherapeutics (AMEX: PLX) is $1.68 last updated September 21, 2023 at 7:59 PM UTC.
Does Protalix BioTherapeutics (PLX) pay a dividend?
There is no dividend information for Protalix BioTherapeutics.
When is Protalix BioTherapeutics (AMEX:PLX) reporting earnings?
Protalix BioTherapeutics’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Protalix BioTherapeutics (PLX) going to split?
There is no upcoming split for Protalix BioTherapeutics.
What sector and industry does Protalix BioTherapeutics (PLX) operate in?
Protalix BioTherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.
Protalix BioTherapeutics Stock (AMEX:PLX), Quotes and News Summary
Protalix BioTherapeutics Stock (AMEX: PLX) stock price, news, charts, stock research, profile.
| Open1.670 | Close1.660 |
| Vol / Avg.330.223K / 899.851K | Mkt Cap120.256M |
| Day Range1.650 - 1.700 | 52 Wk Range1.000 - 3.550 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.040 | 0.210 | 0.2500 | ||||
| REV | 10.220M | 35.075M | 24.855M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2021-05-03 | HC Wainwright & Co. | Raghuram Selvaraju | Maintains | Buy | Lowers | 11.00 | 7.00 |
| 2020-06-08 | HC Wainwright & Co. | Raghuram Selvaraju | Maintains | Buy | Raises | 3.00 | 11.00 |
| 2017-04-17 | Rodman & Renshaw | Raghuram Selvaraju | Reiterates | Buy | Raises | 4.00 | 5.00 |
| 2016-09-06 | Jefferies | - | Maintains | Buy | Lowers | 1.75 | 0.80 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| PLX | Protalix BioTherapeutics | -1.75% | 120.3M |
| GRPH | Graphite Bio | -1.25% | 137.4M |
| ANIX | Anixa Biosciences | 1.19% | 105.6M |
| GALT | Galectin Therapeutics | 0.56% | 106.7M |
| PEPG | PepGen | 2.04% | 131M |
How do I buy Protalix BioTherapeutics (PLX) stock?
You can purchase shares of Protalix BioTherapeutics (AMEX: PLX) through any online brokerage.
Who are Protalix BioTherapeutics's (PLX) competitors?
Other companies in Protalix BioTherapeutics’s space includes: Graphite Bio (NASDAQ:GRPH), Anixa Biosciences (NASDAQ:ANIX), Galectin Therapeutics (NASDAQ:GALT), PepGen (NASDAQ:PEPG) and Gritstone Bio (NASDAQ:GRTS).
What is the target price for Protalix BioTherapeutics (PLX) stock?
The latest price target for Protalix BioTherapeutics (AMEX: PLX) was reported by HC Wainwright & Co. on Monday, May 3, 2021. The analyst firm set a price target for 7.00 expecting PLX to rise to within 12 months (a possible 316.67% upside). 0 analyst firms have reported ratings in the last year.
Current Stock Price for Protalix BioTherapeutics (PLX)?
The stock price for Protalix BioTherapeutics (AMEX: PLX) is $1.68 last updated September 21, 2023 at 7:59 PM UTC.
Does Protalix BioTherapeutics (PLX) pay a dividend?
There is no dividend information for Protalix BioTherapeutics.
When is Protalix BioTherapeutics (AMEX:PLX) reporting earnings?
Protalix BioTherapeutics’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Protalix BioTherapeutics (PLX) going to split?
There is no upcoming split for Protalix BioTherapeutics.
What sector and industry does Protalix BioTherapeutics (PLX) operate in?
Protalix BioTherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.
Protalix BioTherapeutics Stock (AMEX:PLX), Quotes and News Summary
Protalix BioTherapeutics Stock (AMEX: PLX) stock price, news, charts, stock research, profile.
| Open1.670 | Close1.660 |
| Vol / Avg.330.223K / 899.851K | Mkt Cap120.256M |
| Day Range1.650 - 1.700 | 52 Wk Range1.000 - 3.550 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.040 | 0.210 | 0.2500 | ||||
| REV | 10.220M | 35.075M | 24.855M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2021-05-03 | HC Wainwright & Co. | Raghuram Selvaraju | Maintains | Buy | Lowers | 11.00 | 7.00 |
| 2020-06-08 | HC Wainwright & Co. | Raghuram Selvaraju | Maintains | Buy | Raises | 3.00 | 11.00 |
| 2017-04-17 | Rodman & Renshaw | Raghuram Selvaraju | Reiterates | Buy | Raises | 4.00 | 5.00 |
| 2016-09-06 | Jefferies | - | Maintains | Buy | Lowers | 1.75 | 0.80 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| PLX | Protalix BioTherapeutics | -1.75% | 120.3M |
| GRPH | Graphite Bio | -1.25% | 137.4M |
| ANIX | Anixa Biosciences | 1.19% | 105.6M |
| GALT | Galectin Therapeutics | 0.56% | 106.7M |
| PEPG | PepGen | 2.04% | 131M |
How do I buy Protalix BioTherapeutics (PLX) stock?
You can purchase shares of Protalix BioTherapeutics (AMEX: PLX) through any online brokerage.
Who are Protalix BioTherapeutics's (PLX) competitors?
Other companies in Protalix BioTherapeutics’s space includes: Graphite Bio (NASDAQ:GRPH), Anixa Biosciences (NASDAQ:ANIX), Galectin Therapeutics (NASDAQ:GALT), PepGen (NASDAQ:PEPG) and Gritstone Bio (NASDAQ:GRTS).
What is the target price for Protalix BioTherapeutics (PLX) stock?
The latest price target for Protalix BioTherapeutics (AMEX: PLX) was reported by HC Wainwright & Co. on Monday, May 3, 2021. The analyst firm set a price target for 7.00 expecting PLX to rise to within 12 months (a possible 316.67% upside). 0 analyst firms have reported ratings in the last year.
Current Stock Price for Protalix BioTherapeutics (PLX)?
The stock price for Protalix BioTherapeutics (AMEX: PLX) is $1.68 last updated September 21, 2023 at 7:59 PM UTC.
Does Protalix BioTherapeutics (PLX) pay a dividend?
There is no dividend information for Protalix BioTherapeutics.
When is Protalix BioTherapeutics (AMEX:PLX) reporting earnings?
Protalix BioTherapeutics’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Protalix BioTherapeutics (PLX) going to split?
There is no upcoming split for Protalix BioTherapeutics.
What sector and industry does Protalix BioTherapeutics (PLX) operate in?
Protalix BioTherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.